Creating a new method to predict how drugs interact with proteins
Development of a new computational method for predicting drug - target interactions using a TSR-based representation of 3-D structures
['FUNDING_R15'] · UNIVERSITY OF LOUISIANA AT LAFAYETTE · NIH-10363369
This study is exploring a new way to understand how drugs interact with proteins in the body by looking at the shapes of these proteins, which could help create better medicines for people.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF LOUISIANA AT LAFAYETTE (nih funded) |
| Locations | 1 site (LAFAYETTE, UNITED STATES) |
| Trial ID | NIH-10363369 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel computational method that uses a unique representation of protein 3-D structures to predict interactions between drugs and their target proteins. By utilizing a Triangular Spatial Relationship (TSR) approach, the researchers aim to convert complex structural data into meaningful insights that can enhance drug design and discovery. The methodology involves constructing triangles from specific atoms in proteins and assigning unique identifiers to these structures, which helps in classifying proteins based on their functions. This innovative approach could lead to better understanding and identification of drug targets, ultimately improving therapeutic outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that require new or improved drug therapies, particularly those related to protein interactions.
Not a fit: Patients with conditions that are not influenced by drug-target interactions or those who are not seeking new therapeutic options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective drug designs and treatments for various diseases by improving the accuracy of drug-target interaction predictions.
How similar studies have performed: While there have been numerous studies on drug-target interactions, this TSR-based approach is relatively novel and aims to address limitations found in previous methodologies.
Where this research is happening
LAFAYETTE, UNITED STATES
- UNIVERSITY OF LOUISIANA AT LAFAYETTE — LAFAYETTE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: XU, WU — UNIVERSITY OF LOUISIANA AT LAFAYETTE
- Study coordinator: XU, WU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.